Researchers at Mount Sinai Hospital developed an algorithm called HistoAge that predicts age at death based on human brain tissue specimens using artificial intelligence, revealing insights into aging mechanisms and neurodegenerative diseases like Alzheimer's disease.
Researchers found that using predictive models in healthcare can alter relationships between patient data and outcomes, leading to further degradation. Implementing a system to track individuals impacted by machine learning predictions is crucial to maintaining model performance.
Researchers have developed a new approach to treating invasive bladder cancer, combining chemotherapy and immunotherapy, which may preserve quality of life. In a phase 2 clinical trial, approximately 43% of patients achieved complete response without surgical removal of the bladder.
Researchers will investigate risk factors for malignant arrhythmias in mitral valve prolapse, aiming to develop novel indicators and improve patient outcomes. The study will use imaging technology and combine it with other markers to predict the development of arrhythmias over a five-year period.
Researchers identified specific blood biomarkers that can accurately identify patients with long COVID, revealing distinct immune and hormone function differences. The study also found abnormal T cell activity, reactivation of latent viruses, and reduced cortisol levels in patients with long COVID.
Researchers discovered a convergence in potent suppression of interferon-stimulated genes through several viral proteins, including Orf6 and Orf9b, which serve as innate immune antagonist proteins. These findings provide potential new ways to address viral pandemics by targeting a common pathway that the virus uses for infectivity.
A team of researchers has identified a unique pattern in brain activity that reflects the recovery process in patients with treatment-resistant depression. After six months of deep-brain stimulation therapy, 90% of patients exhibited significant improvement in their symptoms and 70% no longer met the criteria for depression.
The Mount Sinai Hospital's Cohen Center will expand its research and clinical care to include 'long Lyme Disease/Lyme+', exploring key similarities and differences with long COVID. The center will offer novel therapies, including virtual reality and non-invasive brain stimulation technologies, as well as personalized cognitive rehabili...
A systematic review of 117 reports from 19 countries found that over half of volunteer community health care workers experience labor exploitation, including sub-minimum-wage pay and excess work hours. The study highlights the need for fair compensation and safe working conditions to improve quality of care and overall health outcomes.
Researchers found that preschoolers from low-income families had poorer health outcomes and improved less in healthy lifestyle habits compared to their peers from more affluent backgrounds. The intervention program showed significant improvements in knowledge, attitudes, and behaviors among children with higher socioeconomic status, bu...
The Mount Sinai Hospital received a $13 million NIH grant to create vaccines that can protect against various types of coronaviruses. The project aims to develop variant-proof, universal vaccines that offer broad protection against existing and future SARS-CoV-2 variants, pandemic, zoonotic, and seasonal coronaviruses.
Researchers have developed an automated breath-by-breath measure to assess the severity of obstructive sleep apnea, predicting cardiovascular disease and mortality. The ventilatory burden tool provides a validated alternative to AHI, offering stable results and risk predictions.
Researchers at Mount Sinai identified the structure of a red blood cell transporter and how it interacts with drugs. They discovered novel compounds capable of blocking the transporter, potentially leading to new treatments for conditions like hemolytic anemias.
Researchers from Mount Sinai found that Asian Americans have a significantly high exposure to PFAS, with median exposure scores 89% higher than non-Hispanic whites. The study used advanced data science methods to account for complex exposure sources and heterogeneity across different groups.
A Mount Sinai study identified the most effective and safest outpatient labor induction methods, using low-dose vaginal misoprostol, which reduces hospital stays and increases hospital efficiency. The study found that this approach does not increase cesarean delivery risk or complications.
Researchers found that the flu blocks lung liquid secretion, allowing staph to infect lungs. Treatment with a CFTR-activating drug like ivacaftor restores liquid secretion and protects against staph infection.
Researchers have discovered a 64-protein signature that can predict which ovarian cancer patients are unlikely to respond to chemotherapy, paving the way for personalized treatment options. The study also identifies five new subtypes of high-grade serous ovarian cancer, suggesting different treatment strategies may be needed.
Researchers aim to understand how psychosocial stress influences cardiovascular health and develop interventions to modulate its effects. The team plans to broaden their perspective on immune reprogramming in stress-aggravated atherosclerotic disease.
Researchers have developed an innovative RNA-based strategy to activate dendritic cells, which play a key role in immune response. The approach, called CATCH, eradicated tumors and prevented their recurrence in mouse models of melanoma, suggesting its potential effectiveness against different cancer types.
A Mount Sinai study published in Nicotine & Tobacco Research found that cigarette smokers are more likely to experience tobacco dependence compared to those who use smokeless tobacco or multiple products. The researchers identified three distinct groups of tobacco users and suggested tailored cessation programs for each group.
Researchers at Mount Sinai discovered a new family of locally secreted molecules called 'mammokines' that play a crucial role in controlling mammary gland fat abundance. These findings have significant implications for breast health, lactation-related disorders, and metabolic syndromes.
A recent study has found that babies born to fathers with psychiatric diagnoses are more likely to be born prematurely. The study analyzed data from over 1.5 million births in Sweden and found a significant increase in preterm births among infants whose father had a psychiatric diagnosis.
Researchers found that individuals with heroin use disorder exhibited a bias towards processing drug cues, while healthy controls showed the opposite pattern. This suggests that efforts to downregulate responses to drug cues may come at the cost of amplifying responses to natural rewards.
A new AI model predicts which existing medicines may lead to congenital disabilities by analyzing genetic associations, drug targets, and gene expression changes. The study's findings have the potential to improve reproductive health and fetal development by identifying potential toxins in new drugs.
Researchers identified significant differences between individuals with CHAMP1 coding mutations and deletions, affecting adaptive functioning skills and severity of symptoms. The study highlights the importance of understanding genetic mechanisms to develop precision medicine approaches for treating CHAMP1 disorder.
Researchers aim to prevent transplant rejection by targeting trained immunity, a newly explored part of the immune system. The five-year program will investigate how trained immunity drives rejection and develop tools for diagnosing and regulating it.
A study found that people with a history of gestational diabetes are more likely to develop type 2 diabetes within nine years after delivery, particularly in Black and Hispanic women. Regular diabetes screenings in the early postpartum period can alter disease progression and improve control.
Researchers identified three immune cell types within tumor niches that determine which patients respond positively to checkpoint blockade immunotherapy. The study may inform new approaches to cancer treatment.
Researchers at Mount Sinai have developed an AI model called HeartBEiT that can analyze electrocardiograms as language, enabling more accurate diagnoses. The model outperformed established methods in comparison tests and demonstrated improved performance with lower sample sizes.
Researchers from Mount Sinai Health System presented new findings on the impact of customized lighting on inpatient sleep, a machine-learned combination of ventilatory, hypoxic, and arousal burdens, and the effects of obstructive sleep apnea and insomnia on cognitive impairment. The studies aim to improve sleep timing and duration, dia...
Researchers have identified a novel model and therapy to mitigate the development of REM sleep behavior disorder, which affects over 3 million Americans. Dual orexin receptor antagonists have been shown to significantly reduce dream enactment behaviors, providing a promising new treatment option.
Researchers from Mount Sinai Health System will present studies on pediatric pulmonary vascular disease, asthma, and sleep disorders. The findings focus on prevalence of pulmonary hypertension in children with severe obstructive sleep apnea and associations between diet and lung function decline.
Dr. George Dangas has been appointed as the new President of SCAI, a non-profit professional association promoting excellence in interventional cardiovascular medicine. He is an authoritative voice on nonsurgical cardiovascular and valve interventions, and will fulfill various responsibilities including acting as spokesperson for SCAI.
A new machine learning-based model predicts individual cardiac surgery patient mortality risk with improved performance over current population-derived models. The model uses electronic health records to provide personalized risk assessments, offering a significant advantage over existing benchmarks.
A global clinical trial found that bioresorbable vascular scaffolds (BVS) are nearly as safe and effective as conventional metal stents in treating coronary artery disease. The study, led by a researcher from the Mount Sinai Hospital, showed improved outcomes for patients when properly implanted.
A new human pangenome reference has been created, capturing significantly more human diversity than the previous single reference. The reference includes genome sequences of 47 people and aims to increase that number to 350 by mid-2024.
Researchers at Mount Sinai have discovered a previously unknown way in which the brain and immune system interact in multiple sclerosis. They found that the inflammatory protein interleukin-3 (IL-3) coordinates this communication, inciting the recruitment of immune cells to the brain and exacerbating brain inflammation.
Researchers at Mount Sinai Hospital developed a machine learning model to analyze wearable device data, identifying an individual's degree of resilience and psychological well-being. The study found that heart rate variability and resting heart rate metrics collected from Apple Watches were predictive of resilience states.
Researchers at Mount Sinai have discovered a new therapeutic approach to treating non-small-cell lung cancer by inhibiting immune system molecule TREM2 and enhancing natural killer cells. The strategy, which involves blocking TREM2 activity using an antibody, has been shown to significantly reduce lung tumor growth in mice.
Researchers at The Mount Sinai Hospital have created versatile disease models of acute myeloid leukemia (AML), allowing for accurate study of the cancer's progression and response to drugs. These models, derived from induced pluripotent stem cells, can mimic different stages of AML and are nearly identical to those found in patients.
Researchers identified potential novel receptors for SARS-CoV-2 that utilize multiple receptors to facilitate its life cycle. The study reveals a strong correlation between tissue age-dependency and SARS-CoV-2 infection-induced receptor expression, with older adults being more susceptible to severe outcomes.
Researchers at the Icahn School of Medicine at Mount Sinai identified previously unknown genetic causes of three rare diseases: primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness. The study used a computational approach to analyze large genetic datasets from rare disease cohorts.
Researchers have identified two novel genes, SRRM2 and AKAP11, linked to schizophrenia. The study suggests that rare damaging variants in these genes confer a similar magnitude of schizophrenia risk across diverse human populations. This finding has implications for the development of new treatments for the disease.
A phase 2 study found that ANGPTL3 inhibitor therapy reduced triglycerides by up to 70% in patients with severe hypertriglyceridemia who had previously experienced acute pancreatitis. The treatment, evicanumab-dgnb, also showed potential for cardiovascular prevention by reducing apolipoprotein B levels.
High-dose anticoagulation reduces intubations and deaths by 30% in hospitalized COVID-19 patients, especially those with ARDS. The study found a significant reduction in mortality and need for ICU care among patients treated with therapeutic anticoagulation.
A new study shows that transcatheter mitral valve repair significantly reduces hospitalizations by almost 50 percent and death by nearly 30 percent in heart failure patients with severe mitral regurgitation. The procedure, using Abbott's MitraClip system, improves symptoms, reduces hospitalizations, and leads to longer survival.
Researchers created a novel approach to deliver anti-cancer drugs directly to brain tumor sites in children, targeting specific locations while sparing normal brain regions. This targeted delivery method enhances the efficacy of existing treatments and reduces adverse side effects.
A recent study published in Immunity found that skipping breakfast can lead to a decline in immune cells and an increased risk of heart disease. The research showed that fasting triggers a stress response in the brain, which negatively affects immune cells.
Scientists have identified key players in the adaptive immune response as culprits for most autoimmunity in people with Down syndrome. The researchers found that many individuals with Down syndrome are in a perpetual state of inflammation comparable to those without the disorder who are in intensive care.
Researchers found 270 distinct differentially methylated regions (DMRs) in AD brains compared to normal controls, validating their key findings using an independent cohort. The study offers a novel approach to investigating the relationship between DNA methylation and gene/protein expression.